[HTML] mdpi.com

[HTML][HTML] In situ Electrochemical Evaluation of the Interaction of dsDNA with the Proteasome Inhibitor Anticancer Drug Bortezomib

MC Bunea, TA Enache, VC Diculescu - Molecules, 2023 - mdpi.com
Bortezomib is an inhibitor of proteasomes and an anti-cancer drug. Although bortezomib is
considered a safe drug, as confirmed by cytotoxicity assays, recent reports highlighted the …
相关文章

In situ Electrochemical Evaluation of the Interaction of dsDNA with the Proteasome Inhibitor Anticancer Drug Bortezomib

MC Bunea, TA Enache… - Molecules (Basel …, 2023 - pubmed.ncbi.nlm.nih.gov
Bortezomib is an inhibitor of proteasomes and an anti-cancer drug. Although bortezomib is
considered a safe drug, as confirmed by cytotoxicity assays, recent reports highlighted the …

In situ Electrochemical Evaluation of the Interaction of dsDNA with the Proteasome Inhibitor Anticancer Drug Bortezomib.

MC Bunea, TA Enache, VC Diculescu - Molecules (Basel …, 2023 - europepmc.org
Bortezomib is an inhibitor of proteasomes and an anti-cancer drug. Although bortezomib is
considered a safe drug, as confirmed by cytotoxicity assays, recent reports highlighted the …

In situ Electrochemical Evaluation of the Interaction of dsDNA with the Proteasome Inhibitor Anticancer Drug Bortezomib.

MC Bunea, TA Enache, VC Diculescu - Molecules, 2023 - search.ebscohost.com
Bortezomib is an inhibitor of proteasomes and an anti-cancer drug. Although bortezomib is
considered a safe drug, as confirmed by cytotoxicity assays, recent reports highlighted the …

In situ Electrochemical Evaluation of the Interaction of dsDNA with the Proteasome Inhibitor Anticancer Drug Bortezomib

MC Bunea, TA Enache, VC Diculescu - Molecules, 2023 - search.proquest.com
Bortezomib is an inhibitor of proteasomes and an anti-cancer drug. Although bortezomib is
considered a safe drug, as confirmed by cytotoxicity assays, recent reports highlighted the …
[PDF] academia.edu

[PDF][PDF] In situ Electrochemical Evaluation of the Interaction of dsDNA with the Proteasome Inhibitor Anticancer Drug Bortezomib

MC Bunea, TA Enache, VC Diculescu - Molecules, 2023 - academia.edu
Bortezomib is an inhibitor of proteasomes and an anti-cancer drug. Although bortezomib is
considered a safe drug, as confirmed by cytotoxicity assays, recent reports highlighted the …
[PDF] mdpi.com

[PDF][PDF] In situ Electrochemical Evaluation of the Interaction of dsDNA with the Proteasome Inhibitor Anticancer Drug Bortezomib

MC Bunea, TA Enache, VC Diculescu - Molecules, 2023 - mdpi.com
Bortezomib is an inhibitor of proteasomes and an anti-cancer drug. Although bortezomib is
considered a safe drug, as confirmed by cytotoxicity assays, recent reports highlighted the …
[HTML] nih.gov

[HTML][HTML] In situ Electrochemical Evaluation of the Interaction of dsDNA with the Proteasome Inhibitor Anticancer Drug Bortezomib

MC Bunea, TA Enache, VC Diculescu - Molecules, 2023 - ncbi.nlm.nih.gov
Bortezomib is an inhibitor of proteasomes and an anti-cancer drug. Although bortezomib is
considered a safe drug, as confirmed by cytotoxicity assays, recent reports highlighted the …

In situ Electrochemical Evaluation of the Interaction of dsDNA with the Proteasome Inhibitor Anticancer Drug Bortezomib

Molecules (Basel, Switzerland), 2023 - europepmc.org
Bortezomib is an inhibitor of proteasomes and an anti-cancer drug. Although bortezomib is
considered a safe drug, as confirmed by cytotoxicity assays, recent reports highlighted the …